Tactile Systems Technology Reveals Strong Q1 2026 Financial Outcomes

Tactile Systems Technology, a company focused on medical devices for treating lymphedema and chronic venous insufficiency, announced impressive financial results for its first quarter of 2026, according to Yahoo Finance. The company experienced substantial upward trends in revenue and profitability, signaling a strong start to the fiscal year. The medical technology innovator's total revenue surged, reaching $71.1 million, marking a considerable 19.3% increase compared to the same period in the prior year. This growth highlights the increasing demand for its specialized medical solutions. A significant contributor to this revenue expansion was the performance of its lymphedema product segment, which generated $64.8 million. This represents a 21.3% rise from the first quarter of the previous year, underscoring the success of its flagship offerings in this therapeutic area. Products addressing chronic venous insufficiency also contributed positively, bringing in $6.3 million, an increase of 2.7% year-over-year. From a profitability standpoint, the company demonstrated notable improvements. Gross profit for the quarter climbed to $51.7 million, up from $43.3 million in the first quarter of 2025. This led to a healthy gross margin of 72.7%, a slight improvement from 72.5% recorded in the comparative period. Operating expenses for the quarter totaled $53.3 million, showing an increase from $48.2 million in the prior year, reflecting ongoing investments in company operations and growth initiatives. Despite increased expenses, the company managed to significantly reduce its net loss. The net loss for the first quarter of 2026 was $1.5 million, a substantial improvement from the $4.9 million net loss reported in the first quarter of 2025. This translates to a diluted loss per share of $0.07, a marked improvement from the $0.23 loss per share in the corresponding period last year. Looking ahead, Tactile Systems Technology has reaffirmed its financial guidance for the full year 2026. The company anticipates full-year revenue to fall between $298 million and $304 million. Gross margin is projected to remain strong, estimated to be between 72.5% and 73.5%. The outlook also forecasts an adjusted EBITDA in the range of $32 million to $36 million, indicating continued expected operational efficiency and profitability.